Loading...
Cerebrospinal fluid GAP-43 in early multiple sclerosis
BACKGROUND/OBJECTIVE: Novel biomarkers identifying and predicting disease activity in multiple sclerosis (MS) would be valuable for primary diagnosis and as outcome measures for monitoring therapeutic effects in clinical trials. Axonal loss is present from the earliest stages of MS and correlates wi...
Na minha lista:
| Udgivet i: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081760/ https://ncbi.nlm.nih.gov/pubmed/30094057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217318792931 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|